What is he best known for?
The fields of study he is best known for:
- Gene
- Genetics
- Internal medicine
His primary areas of investigation include Genetics, Type 1 diabetes, Diabetes mellitus, Allele and Genotype.
His Genetics study focuses mostly on Locus, Human leukocyte antigen, Genetic linkage, Gene and Candidate gene.
His Candidate gene study incorporates themes from Genome-wide association study, Phenotype, Phenome, Interactome and Alzheimer's disease.
His Type 1 diabetes research incorporates elements of Insulin, Susceptibility gene, Disease and Pediatrics.
He has included themes like Mutation, Internal medicine, Pathogenesis and MEDLINE in his Diabetes mellitus study.
His studies in Genotype integrate themes in fields like Offspring, Immunology and Genetic predisposition.
His most cited work include:
- Genome-wide association study and meta-analysis find that over 40 loci affect risk of type 1 diabetes (1358 citations)
- A Taql polymorphism in the human interleukin-1β (IL-1β) gene correlates with IL-1β secretion in vitro (861 citations)
- A human phenome-interactome network of protein complexes implicated in genetic disorders (812 citations)
What are the main themes of his work throughout his whole career to date?
Flemming Pociot focuses on Type 1 diabetes, Genetics, Internal medicine, Endocrinology and Diabetes mellitus.
His Type 1 diabetes study integrates concerns from other disciplines, such as Autoantibody, Immunology, Insulin, Disease and Genotype.
His works in Gene, Candidate gene, Linkage disequilibrium, Human leukocyte antigen and Allele are all subjects of inquiry into Genetics.
His study in Linkage disequilibrium is interdisciplinary in nature, drawing from both Genetic association and Locus.
His Endocrinology research includes elements of Apoptosis and Autoimmune disease.
His Diabetes mellitus research is multidisciplinary, incorporating elements of Gastroenterology, Proteomics, Pediatrics, Cohort and Physiology.
He most often published in these fields:
- Type 1 diabetes (56.50%)
- Genetics (44.00%)
- Internal medicine (40.00%)
What were the highlights of his more recent work (between 2017-2021)?
- Type 1 diabetes (56.50%)
- Internal medicine (40.00%)
- Endocrinology (33.50%)
In recent papers he was focusing on the following fields of study:
Flemming Pociot spends much of his time researching Type 1 diabetes, Internal medicine, Endocrinology, Diabetes mellitus and Immunology.
The various areas that Flemming Pociot examines in his Type 1 diabetes study include Type 2 diabetes, Insulin, Bone remodeling and Cohort.
The Inflammation, Beta cell and Metabolic pathway research he does as part of his general Internal medicine study is frequently linked to other disciplines of science, such as Sensory nerve, therefore creating a link between diverse domains of science.
His work carried out in the field of Diabetes mellitus brings together such families of science as In vitro and Physiology.
He has researched Immunology in several fields, including microRNA and Disease.
His work in the fields of Single-nucleotide polymorphism and In silico overlaps with other areas such as Ethnic group.
Between 2017 and 2021, his most popular works were:
- The emerging role of lncRNAs in inflammatory bowel disease. (34 citations)
- The emerging role of lncRNAs in inflammatory bowel disease. (34 citations)
- Abnormal islet sphingolipid metabolism in type 1 diabetes. (26 citations)
In his most recent research, the most cited papers focused on:
- Gene
- Genetics
- Internal medicine
His primary areas of study are Type 1 diabetes, microRNA, Diabetes mellitus, Immune system and Transfection.
His Type 1 diabetes research is multidisciplinary, incorporating perspectives in Internal medicine, Disease, Cytokine, Bone remodeling and Metabolic control analysis.
Many of his studies involve connections with topics such as Endocrinology and Internal medicine.
His microRNA research is multidisciplinary, relying on both Autoantibody, Antibody, Immunology and Cohort.
Specifically, his work in Immunology is concerned with the study of Tumor necrosis factor alpha.
His Diabetes mellitus research includes themes of Biological activity and In vitro.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
